Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Aytu Biopharma (AYTU) Non-Current Deferred Tax Liability (2021)

Historic Non-Current Deferred Tax Liability for Aytu Biopharma (AYTU) over the last 2 years, with Q4 2021 value amounting to $100000.0.

Aytu Biopharma's Non-Current Deferred Tax Liability changed N/A to $100000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $100000.0, marking a year-over-year change of. This contributed to the annual value of $200000.0 for FY2021, which is N/A changed from last year.
Latest data reveals that Aytu Biopharma reported Non-Current Deferred Tax Liability of $100000.0 as of Q4 2021.
Aytu Biopharma's 5-year Non-Current Deferred Tax Liability high stood at $200000.0 for Q2 2021, and its period low was $100000.0 during Q3 2021.